title: Our experiences with combination of enzyme therapy and laser therapy in enthesopathies.
abstract: The present communication brings a contribution to the confrontation of two treatment methods in enthesopathies (painful overload syndromes). In group A, 26 patients were treated by a combination of systemic enzyme therapy (SET) and non-invasive laser therapy. In group B, 13 persons were treated only by therapeutic laser. The average age in group A and B was of 39.3 and 41.8 years, respectively. The representation of men and women in the two groups was almost identical. The intensity of the pain prior to the treatment and after the treatment, specified by each patient with the help of a ten-grade scale, was evaluated by the variance analysis. The combined treatment by the SET and therapeutic laser was statistically significantly more efficient (p = 0.02). On the other hand, there was also a significant difference between the two groups in baseline values of average pain intensities. These values were of 7.0 and 5.2 in groups A and B, respectively. The average value of the pain intensity in all the 39 patients was of 6.6 prior to the treatment and it was reduced to 3.5 after the treatment.
authors.affiliation: Institute of Biophysics, First Medical Faculty of Charles University, Salmovská 1, 120 00 Prague 2, Czech Republic.
authors.forename: K
authors.initials: K
authors.lastname: Zemanová
authors.forename: D
authors.initials: D
authors.lastname: Svítková-Herényiová
authors.forename: L
authors.initials: L
authors.lastname: Navrátil
authors.forename: V
authors.initials: V
authors.lastname: Foltýnová
mesh_terms: D000284:Administration, Oral; D000328:Adult; D001963:Bromelains / Q000008:administration & dosage; D003131:Combined Modality Therapy; D004338:Drug Combinations; D004798:Enzymes / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage*; D053685:Laser Therapy; D008297:Male; D010147:Pain Measurement; D012216:Rheumatic Diseases / Q000628:therapy*; D012431:Rutin / Q000008:administration & dosage / Q000031:analogs & derivatives*; D014357:Trypsin / Q000008:administration & dosage
chemical_list: D004338:Drug Combinations; D004798:Enzymes; D007155:Immunologic Factors; C056067:rutin sulfate; D012431:Rutin; D001963:Bromelains; D014357:Trypsin